Curis, Inc. (NASDAQ:CRIS) Q3 2024 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the Curis Third Quarter 2024 Business Update Call. At this time, all lines are in a listen-only-mode.
Curis Inc (CRIS)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Maverick Capital Lee Ainslie | 631,827 | $1,933,391 | +9% | 0.03% |
| 2. | M28 Capital Marc Elia | 521,059 | $1,594,441 | +24% | 1.56% |
| 3. | Samsara BioCapital Srini Akkaraju And Michael Dybbs | 198,216 | $606,541 | 0.08% | |
| 4. | Alyeska Investment Group Anand Parekh | 198,216 | $606,541 | 0% | |
| 5. | Renaissance Technologies Jim Simons | 94,072 | $287,860 | +1% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.98 | 25,000 | Director | 51,596 | 2017-11-16 | Filing | |
| $1.06 | 50,000 | Officer, Director | 115,890 | 2017-11-15 | Filing | |
| $2.40 | 10,208,333 | Large Shareholder | 27,328,464 | 2016-09-07 | Filing | |
| $1.60 | 62,890 | Officer, Director | 65,890 | 2014-08-27 | Filing | |
| $2.52 | 3,000 | Officer | 3,000 | 2013-12-11 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.07 | 3,094 | Officer, Director | 64,877 | 2022-01-31 | Filing | |
| $3.18 | 2,406 | Officer, Director | 67,971 | 2022-01-27 | Filing | |
| $10.59 | 3,094 | Officer, Director | 67,268 | 2021-01-26 | Filing | |
| $10.96 | 2,283 | Officer, Director | 70,362 | 2021-01-25 | Filing | |
| $1.64 | 3,094 | Officer, Director | 42,158 | 2020-01-24 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 520,539 | $1,592,849 | 0.4% | |
| 2. | 270,256 | $826,983 | 0% | |
| 3. | 220,000 | $673,200 | 0.61% | |
| 4. | 91,872 | $281,128 | 0% | |
| 5. | 83,129 | $254,431 | 0% |
News See All
Curis, Inc. (NASDAQ:CRIS) Q2 2024 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen. And welcome to the Curis Provides Second Quarter 2024 Business Update Conference Call. At this time, all lines are in listen-only mode.
Curis, Inc. (NASDAQ:CRIS) Q1 2024 Earnings Call Transcript
Curis, Inc. misses on earnings expectations. Reported EPS is $-2.0534 EPS, expectations were $-1.94.
Curis, Inc. (NASDAQ:CRIS) Q4 2023 Earnings Call Transcript
Curis, Inc. misses on earnings expectations. Reported EPS is $-2.03 EPS, expectations were $-1.91. Curis, Inc.
Curis, Inc. (NASDAQ:CRIS) Q3 2023 Earnings Call Transcript
Operator: Good morning, and welcome to Curis' Third Quarter 2023 Business Update Call. All participants will be in a listen-only mode.
Curis, Inc. (NASDAQ:CRIS) Q2 2023 Earnings Call Transcript
Operator: Good afternoon and welcome to the Curis’ Second Quarter 2023 Business Update Call. All participants will be in a listen-only mode.
Curis, Inc. (NASDAQ:CRIS) Q1 2023 Earnings Call Transcript
Operator: Good morning, and welcome to the Curis First Quarter 2023 Business Update Call. Please note, this event is being recorded.
Curis, Inc. (NASDAQ:CRIS) Q4 2022 Earnings Call Transcript
Operator: Good morning, and welcome to the Curis Fourth Quarter 2022 Business Update Call. Please note, this event is being recorded.
5 Stocks to Invest In Under $20 According to Michael Castor's Sio Capital
In this piece, we will take a look at the five stocks to invest in under $20 according to Sio Capital.
5 Best Biotech Stocks Under $5
Agenus Inc. (NASDAQ:AGEN) is a clinical-stage immuno-oncology company based in Lexington, Massachusetts.
Billionaire Hedge Funds
